{
    "nctId": "NCT03099200",
    "briefTitle": "An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast Cancer",
    "officialTitle": "UK HER2 Positive Breast Cancer Productivity & Utility Non-Interventional Study (PURPOSE)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "A Comparison of Productivity, Assessed by Patient-Reported Work Productivity and Activity Impairment (WPAI) Questionnaire Score, of Participants in Cohort 1 vs Cohort 2 vs Cohort 3",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosed with early stage or metastatic (Stage IV) HER2-positive breast cancer (confirmed by the study site physician). \\[HER2-positive is defined as ImmunoHistoChemistry (IHC3+) and/or in situ hybridization (ISH) \u22652.0\\]\n* Able to provide written, informed consent.\n* Early Stage Breast Cancer (eBC) patients must have received at least 1 cycle of adjuvant anti-cancer therapy following surgery; metastatic breast cancer (mBC) patients must have received at least 1 cycle of treatment for their metastatic disease.\n\nExclusion Criteria:\n\n* Unwilling or unable to consent.\n* Unable to complete written quality of life questionnaires\n* Partcipants with Eastern Cooperative Oncology Group (ECOG) Performance Status \u22653",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}